Earnings

sarepta building
Favicon Fierce Pharma

Sarepta CEO to retire, citing 'shocking and ironic twist of fate'

Ingram’s departure comes at a crossroads for Sarepta, as the unwavering conviction that defined his tenure faces major commercial uncertainty.
Angus Liu Feb 26, 2026 11:30am
eraser pencil mistake write cut pen scrub out

Icon reveals accounting investigation, withdraws 2025 guidance

Feb 12, 2026 11:12am
Astellas
Favicon Fierce Pharma

Astellas lifts forecast as Vyloy surge counters trial miss

Feb 5, 2026 11:00am
Multiple screens displaying stock tickers and financial information

GE HealthCare posts higher revenues amid turbulent tariffs

Feb 5, 2026 10:45am
Make a delay and accumulation of outstanding tasks Full stop

Daiichi stops internal development of next-wave ADC

Feb 2, 2026 10:55am
Illustration connected puzzle pieces with the acronym MA
Favicon Fierce Pharma

Halozyme catches M&A wave to snap up Surf Bio

Jan 28, 2026 2:06pm